AT1 FY21 - General Discussion + FA, page-1272

@Soul13
Yes, that's right, My account is with Bell Potter already, so I would apply when they put a notice out.

No, you shouldn't need to be a client of the listing agents - they are usually happy to work through existing brokers. You should be able to arrange it through your broker to submit application/seek an allocation OR you can apply directly through Bell/Wilson (whoever are the final listing agents). Then once the allocation is approved, shares would be be issued+registered with your brokerage account - the detail will be there in the prospectus (once it comes out) on how and where to apply.

Yes, it might get rejected/not allocated (and clarification, something in the prospectus might not look right or IPO price might be too high or too much future options/dilution being built in etc....but for now I do plan to invest, since I feel I understand Lumos' current biz state + I like the FebriDx IP niche for the much larger antibiotic reduction market, which has a lot of potential private sector and gov funding expected for next decade. However I would like to see what are Lumos' plans for beyond FebriDx product, as it might be too narrow moat then to invest a lot in 2021...have to see..).